Diligence memo · auto-generated · as of July 2, 2026
Phoenix Biotechnology Inc
Phoenix Biotechnology Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Phoenix Biotechnology Inc operates in Pharmaceuticals, based in SAN ANTONIO.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Phoenix Biotechnology Inc has raised $11M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.0M on 2020-08-07.
Most recent recorded round closed around 2020-08-07.
Valuation (modeled)modeled
Provath models Phoenix Biotechnology Inc at approximately $148M (range $5.7M–$787M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.97× the median modeled value of Series A Pharmaceuticals companies in 2019–2021 (76 peers) — value vs value, same stage and era. Within the normal band (97% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 5.9 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 4.8× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 56% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 63% of those peers.
Closest niche peers: Xynomic Pharmaceuticals Holdings, Inc., Honest Globe Inc., Athenen Therapeutics, Inc., Zomedica Pharmaceuticals Corp., CerSci Therapeutics Inc..
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.